The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable excitement within the industry. A shift away from Schedule I status, often viewed as outdated and hindering https://ok-social.com/story6288133/cannabinoid-rescheduling-a-expansion-catalyst